| Disease | IN A COMPARATIVE DOUBLE-BLIND STUDY, GINKGO BILOBA EXTRACT (GBE, 4% SOLUTION IN DROPS) 80 MG BID WAS INVESTIGATED VERSUS PLACEBO IN 80 SUBJECTS WITH PSYCHORGANIC SENILE DEMENTIA OF ARTERIOSCLEROTIC ORIGIN. EFFICACY WAS EVALUATED USING A CLINICAL
GERIATRIC SCALE (SCAG) AND A PSYCHOMETRIC TEST (TOULOUSE-PIERON) CARRIED OUT BEFORE (BASELINE) AND AFTER THE 6 WEEK TREATMENT. THE RESULTS CONFIRM THE EFFICACY AND GOOD TOLERABILITY OF THE DRUG, WHICH HAS ALREADY BEEN DOCUMENTED IN THE
LITERATURE. IN PARTICULAR, THE SUM OF THE SCAG SCORES WAS STATISTICALLY SIGNIFICANT IN THE COMPARISON OF GBE BASELINE VS. FINAL VALUES AND OF GBE VS. PLACEBO (FINAL VS. FINAL VALUES). LIKEWISE, THE "BEFORE" AND "AFTER" COMPARISONS FOR NUMEROUS
PARAMETERS IN THE SCAG (MOOD DEPRESSION, LACK OF MOTIVATION, IRRITABILITY, HOSTILITY, FATIGUE, ETC.) WERE SIGNIFICANT. WITH REGARD TO VARIATIONS IN APPERCEPTION AS EVALUATED BY THE PSYCHOMETRIC TEST, THE COMPARISON OF GBE VS. PLACEBO WAS
SIGNIFICANT ONLY WITH REGARD TO THE NUMBER OF INCORRECT IDENTIFICATIONS. |